Quick Answer
Allarity Therapeutics, Inc. reported Shares Outstanding of 16.08 million shares for fiscal year 2025.
Allarity Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 16.08M | +120.2% |
| 2024 | 7.30M | +74327.2% |
| 2023 | 9,812 | -13.6% |
| 2022 | 11,356 | -99.9% |
| 2021 | 8.10M | +90.4% |
| 2020 | 4.25M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 16.11M | +483.9% | +10.2% |
| June 30, 2025 | 14.62M | -58.3% | -14.1% |
| March 31, 2025 | 17.02M | +7349.9% | +133.1% |
| December 31, 2024 | 7.30M | +74327.2% | +164.7% |
| September 30, 2024 | 2.76M | -34.1% | -92.1% |
| June 30, 2024 | 35.04M | +6857.7% | +15235.3% |
| March 31, 2024 | 228,487 | -80.8% | +2228.6% |
| December 31, 2023 | 9,812 | -97.8% | -99.8% |
- Allarity Therapeutics, Inc. showed an increase of +120.2% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, Allarity Therapeutics, Inc.’s shares outstanding has grown by 278.2% (from 4.25 million shares to 16.08 million shares).
- The most recent figure is from Allarity Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: